Stay updated on Pediatric Cabozantinib Clinical Trial
Sign up to get notified when there's something new on the Pediatric Cabozantinib Clinical Trial page.

Latest updates to the Pediatric Cabozantinib Clinical Trial page
- Check3 days agoChange DetectedA site-wide notice announces NIH’s terminology transition from “Artificial Intelligence” to “Super Intelligence” under Executive Order 14434 and links to related updates and FAQs.SummaryDifference1%

- Check10 days agoChange DetectedThe footer revision number changes from v3.7.1 to v3.7.2, while the page continues to display a 403 error.SummaryDifference0.2%

- Check17 days agoChange DetectedThe footer revision identifier changed from v3.7.0 to v3.7.1 on the ClinicalTrials.gov page displaying a 403 Forbidden error.SummaryDifference0.2%

- Check38 days agoChange DetectedThe page now displays a 403 Forbidden error, replacing the previously visible study record content with an access-restricted message; the layout shows standard header/footer/navigation for an error page.SummaryDifference19%

- Check60 days agoChange DetectedAdded Kaiser Permanente-Rio San Diego as a study site and removed Kaiser Permanente-San Diego Mission, updating the list of participating locations. The document version was updated to v3.6.6.SummaryDifference0.1%

- Check67 days agoChange DetectedNo textual changes were provided for the page. The study details remain as described in the current text given.SummaryDifference0.0%

Stay in the know with updates to Pediatric Cabozantinib Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pediatric Cabozantinib Clinical Trial page.